Genetic testing for DYSF mutations is the gold standard for clinical diagnosis, and Western blot testing for dysferlin deficiency in monocytes, combined with clinical manifestations, can also diagnose dysferlinopathy (Shin et al., 2015). The gene discussed is DYSF; the disease is neuromuscular disease caused by qualitative or quantitative defects of dysferlin.